Nov 9, 2024, 20:08
Dr. Sara Tolaney Discusses ESMO24 Insights on TroFuse-010 Trial in Advanced Breast Cancer
Dana-Farber’s Breast Oncology Center shared the following on X:
“Dr. Sara Tolaney discussed ESMO24 Insights in a new VuMedi video on the TroFuse-010 Trial – Sacituzumab Govitecan ± Pembro vs. Chemo in HR+/HER2- Advanced Breast Cancer.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 19:34
Nov 12, 2024, 19:26
Nov 12, 2024, 18:59
Nov 12, 2024, 18:58
Nov 12, 2024, 18:55
Nov 12, 2024, 18:46